Best rehabilitation therapists: TOP 383 doctors

Doctor with experience in metabolic control of diabetic and hypertensive patients and a diploma in Diabetology. Current Medical Director of GIOSTAR Mexico in Los Algodones Mexicali Baja California since 2017. Graduated from Autonomous University of Guadalajara and has experience in patient admission, external medical service and emergencies in multiple private hospitals.

Prof.  Roberto Gatti is the Physiotherapy Unit Director in Humanitas Research Hospital. Prof. Roberto Gatti became physiotherapist in 1985 at the University of Milan (Italy). In 1996 he got the licénce en kinésithérapie et réadaptation  at the Catholique University of Louvain la Neuve (Belgium) and, in 2009, the Master of sciences in Rehabilitation Sciences at the University of Florence (Italy).

Medical areas of interest: 

motor rehabilitation

Previous experience:
 

Didactic coordinator of Physiotherapy degree programme of the Vita-Salute San Raffaele University

• Group Leader of the Motor Function Analysis and Rehabilitation Laboratory of the Department of Neuroscience of San Raffaele Hospital
• Head of physiotherapy at San Raffaele Hospital

Research areas of interest:

Research lines of Prof. Roberto Gatti are mainly addressed on Biomechanics and Neurorehabilitation, with a focus on the effects of cognitive facilitations (i.e. action observation) on motor relearning of subjects with lesion at the central nervous system. As Biomechanics research lines his interest is focused on the study of anticipatory postural adjustments and their coordination with the agonist component of movement.

Teaching experience: 

Associated Director of the Physiotherapy degree programme of Humanitas Research Hospital since 2016

Experience

2016 - 2019 Özel Gebze Konak Hastanesi

2014 - 2015 Özel Medicana Çamlıca Hastanesi

2013 - 2014 Özel Batman Hastanesi

2011 - 2013 Batman Bölge Devlet Hastanesi

Üsküdar Üniversitesi

Gazi Üniversitesi Tıp Fakültesi

Education

2011 Bezmialem Vakıf Üniversitesi Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon

2005 Marmara Üniversitesi, İngilizce Tıp Fakültesi

EXPERIENCE*

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

*EDUCATION*

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

2018 - Halen, İstanbul/İstanbul/Türkiye

MEMORIAL ATAŞEHİR HASTANESİ

Fiziksel Tıp ve Rehabilitasyon ve Algoloji Uzmanı

2002 - 2018, Ankara/Ankara/Türkiye

GATA TIP FAKÜLTESİ

Fiziksel Tıp ve Rehabilitasyon AD. Öğretim Üyesi

2000 - 2002, Erzurum/Erzurum/Türkiye

MAREŞAL ÇAKMAK ASKERİ HASTANESİ

Fizik Tedavi ve Rehabilitasyon Uzmanı

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21